Gary S Jacob Virpax Pharmaceuticals, Inc. (VRPX) insider trading activity

VRPX Quotes by TradingView

Gary S Jacob is Director of Virpax Pharmaceuticals, Inc.. Currently has a direct ownership of 3,500 shares of VRPX, which is worth approximately $2,450. The most recent transaction as insider was on Feb 17, 2021, when has been sold 3,500 shares (Common Stock, $0.00001 par value) at a price of $6.79 per share, resulting in proceeds of $23,765. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.5K
0% 3M change
0% 12M change
Total Value Held $2,450

GARY S JACOB Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2021
BUY
Open market or private purchase
$23,765 $6.79 p/Share
3,500 Added 50.0%
3,500 Common Stock, $0.00001...

Also insider at

CRDF
Cardiff Oncology, Inc. Healthcare
HEPA
Hepion Pharmaceuticals, Inc. Healthcare
Director
OKYO
OKYO Pharma Ltd Healthcare
Chief Executive Officer
GSJ

Gary S Jacob

Director
Edison, NJ

Track Institutional and Insider Activities on VRPX

Follow Virpax Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRPX shares.

Notify only if

Insider Trading

Get notified when an Virpax Pharmaceuticals, Inc. insider buys or sells VRPX shares.

Notify only if

News

Receive news related to Virpax Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VRPX